Logos Global Management LP Sarepta Therapeutics, Inc. Transaction History

Logos Global Management LP

$756 Million
Q3 2024

A detailed history of Logos Global Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 150,000 shares of SRPT stock, worth $16.6 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares

150,000

Previous 150,000 -0.0%

Holding current value

$16.6 Million

Previous $23.7 Million 20.95%

% of portfolio

2.48%

Previous 2.22%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $28.3 Million - $41 Million	-250,000 Reduced 62.5%	150,000 $23.7 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $37.5 Million - $56.6 Million	400,000 New	400,000 $51.8 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $10.3 Million - $12.4 Million	-100,000 Reduced 33.33%	200,000 $24.2 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $8.51 Million - $12.6 Million	80,000 Added 36.36%	300,000 $34.4 Million
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $13.1 Million - $17.2 Million	-130,000 Reduced 37.14%	220,000 $28.5 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $3.79 Million - $5.96 Million	-50,000 Reduced 12.5%	350,000 $38.7 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $25.1 Million - $35.4 Million	400,000 New	400,000 $30 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $34.5 Million - $49.2 Million	-275,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $35 Million - $47.4 Million	275,000 New	275,000 $38.6 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $17.4 Million - $32.2 Million	-187,350 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $3.18 Million - $5.09 Million	-38,652 Reduced 17.1%	187,350 $18.3 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $17.3 Million - $30.6 Million	226,002 New	226,002 $29.2 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.71B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Account

Logos Global Management LP Sarepta Therapeutics, Inc. Transaction History